Non-invasive cardiac and pulmonary pressure sensing
Helping healthcare professionals identify hemodynamic congestion and personalize heart failure therapy
Cardiac and pulmonary pressures as a way of understanding and managing heart failure
The non-invasive SAVE Sensor System
A first-of-its-kind multi-modal platform built on Seismic, Acoustic, Visual and Electric sensors
Clinically tested in over 2000 patients
Recruitment across 20 hospitals in 6 countries vs. Right Heart Catheterization ground truth
Absolute and actionable outputs
Left-sided (PCWP) and right-sided (RAP) pressure insights combined with hemodynamic congestion trends
Repetable and easy to use
Handheld and portable form factor for seamless clinical worfklow integration
Accurate, absolute & actionable non-invasive intracardiac pressure monitoring
Accurate
The objective of the Acorai Heart Monitor is to offer accurate estimations of pulmonary pressure to support personalized heart failure treatment
Absolute
The Save Sensor System is a first-of-its-kind hardware architecture and machine learning with absolute intracardiac insights in mind.
Actionable
An ongoing clinical study (CAPTURE-HF) aims to confirm if the monitor can deliver actionable information equal to invasive methods.
<span data-metadata=""><span data-buffer="">Acorai is working to enable data that can alleviate healthcare burdens
Readmission rates & penalties
Ensuring that patients are stable prior to discharge reduced reamission rates
Length of stay
A better understanding of patient stability enables better discarge decisions
Complications
Continuous monitoring improves medication decisions and patient stability
As demonstrated by LAPTOP-HF, COMPASS-HF, PARADIGM-HF, CHAMPION TRIAL, GUIDE-HF & MONITOR-HF
Working with world-leading partners to push the boundaries of cardiac care
Saint Luke’s Health System consists of 16 area hospitals and campuses and several primary and specialty care practices, and provides a range of inpatient
Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world.
The Västra Götaland region works to stimulate research in healthcare in collaboration with universities and business.
Life Science Invest has so far investedin 20 life science companies. In the coming year, it is intended to invest with a focus on companies in the start-up phase.
KHP Ventures is a King’s College London, King’s College Hospital NHS Foundation Trust & Guy’s and St Thomas’ Hospital NHS Foundation Trust collaboration.
EIT Health Gold Track program helps the brightest minds to explore new ideas & find practical resources to create products & services rooted in innovation.
Explore our latest news and insights
Join us in transforming heart failure management
Follow our journey!
